Related Experiment Videos
Protection against cytotoxic-induced testis damage--experimental approaches
1Molecular Pharmacology and Toxicology, Physiological Sciences, University of Manchester, UK.
European Urology
|January 1, 1993
Summary
Pharmacological inhibition of cell division may preserve fertility during cancer treatment. Animal models show inconsistent results, highlighting the need for further research to establish effective fertility-sparing strategies.
Area of Science:
- Reproductive biology
- Oncology
- Pharmacology
Background:
- Cancer treatments like chemotherapy and radiation can cause infertility by damaging sperm-producing cells.
- Preserving fertility in cancer patients is a significant concern, prompting research into protective strategies.
Purpose of the Study:
- To review animal model studies investigating the efficacy of pharmacological inhibition of spermatogenesis to preserve fertility during cytotoxic cancer therapy.
Main Methods:
- Review of recent animal studies (rats and mice) examining the protective effects of gonadotrophin-releasing hormone (GnRH) analogues, progestogens, and androgens against cytotoxic agents and radiation.
- Assessment of the impact of these interventions on spermatogenesis and fertility preservation.
Main Results:
- In rats, GnRH analogues or progestogen-androgen combinations protected spermatogenesis from procarbazine and radiation but not cyclophosphamide.
- In mice, GnRH analogues failed to protect against cisplatin-induced testicular toxicity.
- Complete suppression of spermatogenesis was not essential for successful fertility preservation.
Conclusions:
- Animal models show variable efficacy of pharmacological approaches to preserve fertility during cancer treatment, indicating a need for further research.
- Establishing reliable pharmacological strategies and understanding their mechanisms in animal models is crucial before predicting efficacy in human cancer patients.